ARTICLE | Company News
Meditrina, AstraZeneca deal
February 11, 2008 8:00 AM UTC
AstraZeneca granted Meditrina exclusive, worldwide rights to IP covering aromatase inhibitors in combination with estrogen and progestin to treat endometriosis. Financial terms were not disclosed. Me...